(Q47899828)

6 February 2018

editorial

0 references

title

Selective COX-2 inhibitors: are they safe for the stomach? (English)

1 reference

6 February 2018

author name string

Yeomans ND

series ordinal

1

1 reference

6 February 2018

Cook GA

series ordinal

2

1 reference

6 February 2018

Giraud AS

series ordinal

3

1 reference

6 February 2018

language of work or name

English

0 references

publication date

1 July 1998

1 reference

6 February 2018

published in

Gastroenterology

1 reference

6 February 2018

volume

115

1 reference

6 February 2018

issue

1

1 reference

6 February 2018

page(s)

227-229

1 reference

6 February 2018

PGH synthase isoenzyme selectivity: the potential for safer nonsteroidal antiinflammatory drugs

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970388-9

Mechanism of action of nonsteroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970388-9

Cyclooxygenase 1 contributes to inflammatory responses in rats and mice: implications for gastrointestinal toxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970388-9

Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970388-9

Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970388-9

Cyclo-oxygenase isozymes in mucosal ulcergenic and functional responses following barrier disruption in rat stomachs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970388-9

Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970388-9

Selective cyclo-oxygenase-2 inhibitors and their influence on the protective effect of a mild irritant in the rat stomach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970388-9

Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970388-9

Effects of nimesulide, a preferential cyclooxygenase-2 inhibitor, on carrageenan-induced pleurisy and stress-induced gastric lesions in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970388-9

Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastro-intestinal ulcer models in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970388-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970388-9

A 4-week, double-blind, parallel-group study to compare the gastrointestinal effects of meloxicam 7.5 mg, meloxicam 15 mg, piroxicam 20 mg and placebo by means of faecal blood loss, endoscopy and symptom evaluation in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970388-9

Meloxicam in osteoarthritis: a 6-month, double-blind comparison with diclofenac sodium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970388-9

A long-term study to evaluate the safety and efficacy of meloxicam therapy in patients with rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970388-9

A double-blind, three-week study to compare the efficacy and safety of meloxicam 7.5 mg and meloxicam 15 mg in patients with rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970388-9

A randomized, double-blind, crossover comparative endoscopy study on the gastroduodenal tolerability of a highly specific cyclooxygenase-2 inhibitor, flosulide, and naproxen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970388-9

Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970388-9

10.1016/S0016-5085(98)70388-9

7 January 2021

Identifiers

DOI

1 reference

6 February 2018

release_rj6wel27tbcw7lg5tynesohnea

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rj6wel27tbcw7lg5tynesohnea

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

9649482

1 reference

6 February 2018